Latest / Cleveland Clinic Cancer Advances
CAR T and Bispecific Therapies in AL Amyloidosis
Hematologist and myeloma specialist Shahzad Raza, MD, joins the Cancer Advances podcast to discuss emerging cellular and immune therapies for AL amyloidosis. Listen as Dr. Raza reviews early data on CAR T-cell therapy and bispecific antibodies, their potential to induce deep hematologic responses and how these approaches may improve organ function and long-term outcomes for patients with this rare plasma cell disorder.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.